The Cancer Advances podcast is joined by Shahzad Raza, MD, a hematologist at Cleveland Clinic Cancer Center, discussing eye toxicities linked to cancer treatments. Listen as Dr. Raza talks about his study examining real-world experiences compiling eye toxicities from several anticancer drugs. During the podcast, he emphasizes the importance of the early involvement of ophthalmologists in patient care and incorporating ophthalmology exams in clinical trials.
The Cancer Advances podcast is joined by Shahzad Raza, MD, a hematologist at Cleveland Clinic Cancer Center, discussing eye toxicities linked to cancer treatments. Listen as Dr. Raza talks about his study examining real-world experiences compiling eye toxicities from several anticancer drugs. During the podcast, he emphasizes the importance of the early involvement of ophthalmologists in patient care and incorporating ophthalmology exams in clinical trials.